Rodec Pharma Limited, a active public limited company, was established on 18 November 1997 in New Delhi, Delhi, India. Engaging in animal pharmaceuticals & healthcare within the trade sector, it holds CIN: U24233DL1997PLC090729. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹25.00 Cr and a paid-up capital of ₹22.58 Cr.
Formerly known as Rodec Pharmaceuticals Private Limited. It upholds a compliant status. Its leadership includes Chhaya Gupta (Director), Utkarsh Gupta (Director), Mukesh Kumar Gupta (Director). Past directors included Utkarsh Gupta, Shubhangi Gupta, Keshav Kumar Sharma. It holds ₹142.48 Cr open charges and ₹8.51 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at F-46, Pankaj Central Market I.P Extension, Patparganj, New Delhi, Delhi, 110092.
U24233DL1997PLC090729
090729
18 November 1997
₹25.00 Cr
₹22.58 Cr
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Rodec Pharma Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Chhaya Gupta | Director | 18 Nov 1997 | Current |
| Utkarsh Gupta | Director | 24 Mar 2023 | Current |
| Mukesh Kumar Gupta | Director | 01 Dec 2000 | Current |
| Achal Kapoor | Additional Director | 23 Aug 2025 | Current |
| Nikita Sinha | Additional Director | 23 Aug 2025 | Current |
| Preeti | Additional Director | 23 Aug 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 29 Sep 2023 | Past |
| Pramod Abcsdd | Director | 24 Mar 2023 | Past |
| Pramod Abcsdd | Company Secretary | - | Past |
| Pramod Abcsdd | Cfo | - | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Rodec Pharma Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 25.35% increase. The company also saw a substantial improvement in profitability, with a 23.19% increase in profit. The company's net worth Soared by an impressive increase of 34.67%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Rodec Pharma had a promoter holding of 86.10% and a public holding of 13.90%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹1,424,832,000.00
₹85,121,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 22 Aug 2024 | Hdfc Bank Limited | ₹3.00 M | Open |
| 22 Jun 2023 | Hdfc Bank Limited | ₹1.66 M | Open |
| 29 Dec 2022 | Hdfc Bank Limited | ₹1.00 Cr | Open |
| 28 Jun 2022 | Hdfc Bank Limited | ₹140.50 Cr | Open |
| 19 Nov 2020 | Axis Bank Limited | ₹5.17 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Rodec Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Rodec Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rodec Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Shivam Gupta was appointed as a Cfo was appointed as a Cfo on 22 Nov 2025 & has been associated with this company since 9 days . was completed.
Keshav Kumar Sharma was appointed as a Company Secretary was appointed as a Company Secretary on 07 Sep 2025 & has been associated with this company since 2 months 26 days . was recorded as a recent event.
The activity Achal Kapoor was appointed as a Additional Director was appointed as a Additional Director on 23 Aug 2025 & has been associated with this company since 3 months 10 days . was completed.
Nikita Sinha was appointed as a Additional Director was appointed as a Additional Director on 23 Aug 2025 & has been associated with this company since 3 months 10 days . was recorded as a recent event.
Progress on Preeti was appointed as a Additional Director was appointed as a Additional Director on 23 Aug 2025 & has been associated with this company since 3 months 10 days . was documented.
The activity A charge with Hdfc Bank Limited of Rs. 140.50 Cr registered on 28 Jun 2022 with Charge ID 100602715 was modified on 06 May 2025. was completed.
The CIN of Rodec Pharma Limited is U24233DL1997PLC090729.
Rodec Pharma Limited is headquartered at F-46, Pankaj Central Market I.P Extension, Patparganj, New Delhi, Delhi, 110092.
Rodec Pharma Limited was incorporated on 18 November 1997.
The current directors of Rodec Pharma Limited are
The primary industry of Rodec Pharma Limited is Trade.
Rodec Pharma Limited is unlisted.
The authorized capital of Rodec Pharma Limited is ₹25.00 Cr, and the paid-up capital is ₹22.58 Cr.
The compliance status of Rodec Pharma Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX